Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPPA-2 (PS-2)
2005-005631-97Phase 3Terminated
- Sponsor
- Istituto Nazionale Tumori IRCCS Fondazione Pascale
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of gemcitabine and cisplatin in cancer, sponsored by Istituto Nazionale Tumori IRCCS Fondazione Pascale. Started Jul 2007; status: terminated.
02
Drugs
gemcitabinecisplatin
03
Conditions
cancer
Beyond the preview
Go deeper on 2005-005631-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005631-97.